+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 133 Pages
  • July 2022
  • Region: Global
  • IMARC Group
  • ID: 5633295
The global genetic testing market reached a value of US$ 14.36 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 26.39 Billion by 2027, exhibiting a CAGR of 10.67% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.



Genetic testing, or deoxyribonucleic acid (DNA) testing, refers to a medical technique that identifies changes in the chromosome structure or DNA sequence. It includes the collection and analysis of individual blood samples for examining the genetic condition and the chances of developing or passing various inherited disorders in laboratory settings. Genetic testing assists in providing accurate results regarding gene mutation, eliminating the need for unnecessary checkups, and making informed decisions to manage health. At present, genetic testing is commercially available in varying types, such as carrier, diagnostic, predictive, presymptomatic and prenatal testing.

Genetic Testing Market Trends:

The increasing prevalence of genetic and chronic disorders across the growth represents the key factor driving the genetic testing market growth. This is further supported by the implementation of numerous favorable initiatives undertaken by the government bodies and non-governmental organizations (NGOs) for sensitizing masses regarding genetic testing. In line with this, the extensive utilization of genetic testing in pharmacogenomics, or drug-gene testing for examining the response of the body against certain medicines after its interaction with inherited genes, is contributing as another growth-inducing factor. Additionally, the sudden outbreak of coronavirus disease (COVID-19) pandemic has led to the widespread adoption of virtual testing and the home testing kits for sample collection purposes, which, in turn, is contributing to the market growth. The tremendous technological advancements in genetic testing techniques along with the introduction of DTC-GT (Direct-to-consumer genetic testing) kits are further propelling the market growth. Other factors, such as rising investments in the research and development (R&D) activities in the field of medical science, along with the strategic collaboration amongst top players for launching advanced personalized genetic testing kits, are creating a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global genetic testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, technology and application.

Breakup by Type:

  • Predictive and Presymptomatic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

Breakup by Technology:

  • Cytogenetic Testing and Chromosome Analysis
  • Biochemical Testing
  • Molecular Testing
  • DNA Sequencing
  • Others

Breakup by Application:

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Others

Breakup by Region:

North America

  • United States
  • Canada

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global genetic testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global genetic testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genetic testing market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Genetic Testing Market

What is the estimated value of the Global Genetic Testing Market?

The Global Genetic Testing Market was estimated to be valued at $14.4 Billion in 2021.

What is the growth rate of the Global Genetic Testing Market?

The growth rate of the Global Genetic Testing Market is 10.6%, with an estimated value of $26.4 Billion by 2027.

What is the forecasted size of the Global Genetic Testing Market?

The Global Genetic Testing Market is estimated to be worth $26.4 Billion by 2027.

Who are the key companies in the Global Genetic Testing Market?

Key companies in the Global Genetic Testing Market include 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio, RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation and Myriad Genetics Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genetic Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Predictive and Presymptomatic Testing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Carrier Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Prenatal and Newborn Testing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Diagnostic Testing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Pharmacogenomic Testing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Technology
7.1 Cytogenetic Testing and Chromosome Analysis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biochemical Testing
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Molecular Testing
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 DNA Sequencing
7.3.2.1 Others
7.3.3 Market Forecast
8 Market Breakup by Application
8.1 Cancer Diagnosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Genetic Disease Diagnosis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Disease Diagnosis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 23andme Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cepheid (Danaher Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Eurofins Scientific
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Illumina Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Invitae Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Luminex Corporation (DiaSorin)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Myriad Genetics Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Quest Diagnostics
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
Figure 2: Global: Genetic Testing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2021
Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2021
Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2021
Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2021
Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: North America: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: United States: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Canada: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: China: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Japan: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: India: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Australia: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Others: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Europe: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Germany: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: France: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Italy: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Spain: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Russia: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Others: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2021
Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Global: Genetic Testing Industry: SWOT Analysis
Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Genetic Testing Market: Competitive Structure
Table 7: Global: Genetic Testing Market: Key Players

Companies Mentioned

  • 23andme Inc.
  • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
  • Bio-RAD Laboratories Inc.
  • Cepheid (Danaher Corporation)
  • Eurofins Scientific
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation (DiaSorin)
  • Myriad Genetics Inc.
  • QIAGEN
  • Quest Diagnostics
  • Thermo Fisher Scientific.

Methodology

Loading
LOADING...